AWM
GSK icon

Accredited Wealth Management’s GSK GSK Stock Holding History

Accredited Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$9.18K Sell
50
-160
-76% -$6.25K 0.01% 273
2025
Q2 		$8.16K Sell
210
-337
-62% -$12.9K 0.01% 285
2025
Q1 		$21.4K Hold
547
– – 0.02% 175
2024
Q4 		$18.8K Buy
+547
New +$19.7K 0.02% 202

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Accredited Wealth Management's GSK Position: Q3 2025 in Review

Accredited Wealth Management reduced its GSK (GSK) stake by 76% in Q3 2025, selling an estimated $6.25K and leaving 50 shares worth $9.18K. The position accounts for 0.01% of the portfolio, ranked #273.

Accredited Wealth Management first reported a position in GSK in Q4 2024 and has held it in 4 quarters since. The position peaked at $21.4K in Q1 2025. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Accredited Wealth Management held 50 shares of GSK worth $9.18K as of Q3 2025.
  • Accredited Wealth Management sold 160 GSK shares in Q3 2025, an estimated $6.25K.
  • GSK made up 0.01% of Accredited Wealth Management's portfolio in Q3 2025, its #273 holding.
  • Accredited Wealth Management first reported a position in GSK in Q4 2024 and has held it in 4 quarters since.
  • Accredited Wealth Management's GSK position peaked at $21.4K in Q1 2025.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Accredited Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.